1. Home
  2. BNR vs NWGL Comparison

BNR vs NWGL Comparison

Compare BNR & NWGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNR
  • NWGL
  • Stock Information
  • Founded
  • BNR 2014
  • NWGL 2008
  • Country
  • BNR China
  • NWGL Macau
  • Employees
  • BNR N/A
  • NWGL N/A
  • Industry
  • BNR Medical Specialities
  • NWGL
  • Sector
  • BNR Health Care
  • NWGL
  • Exchange
  • BNR Nasdaq
  • NWGL Nasdaq
  • Market Cap
  • BNR 29.1M
  • NWGL 26.2M
  • IPO Year
  • BNR 2020
  • NWGL 2023
  • Fundamental
  • Price
  • BNR $3.86
  • NWGL $1.08
  • Analyst Decision
  • BNR
  • NWGL
  • Analyst Count
  • BNR 0
  • NWGL 0
  • Target Price
  • BNR N/A
  • NWGL N/A
  • AVG Volume (30 Days)
  • BNR 35.7K
  • NWGL 817.1K
  • Earning Date
  • BNR 08-21-2025
  • NWGL 07-22-2025
  • Dividend Yield
  • BNR N/A
  • NWGL N/A
  • EPS Growth
  • BNR N/A
  • NWGL N/A
  • EPS
  • BNR N/A
  • NWGL N/A
  • Revenue
  • BNR $72,112,038.00
  • NWGL $21,539,347.00
  • Revenue This Year
  • BNR $136.32
  • NWGL N/A
  • Revenue Next Year
  • BNR N/A
  • NWGL N/A
  • P/E Ratio
  • BNR N/A
  • NWGL N/A
  • Revenue Growth
  • BNR 0.53
  • NWGL N/A
  • 52 Week Low
  • BNR $2.18
  • NWGL $0.91
  • 52 Week High
  • BNR $7.90
  • NWGL $6.61
  • Technical
  • Relative Strength Index (RSI)
  • BNR 62.38
  • NWGL 45.42
  • Support Level
  • BNR $3.06
  • NWGL $1.02
  • Resistance Level
  • BNR $3.50
  • NWGL $1.21
  • Average True Range (ATR)
  • BNR 0.23
  • NWGL 0.50
  • MACD
  • BNR 0.03
  • NWGL -0.07
  • Stochastic Oscillator
  • BNR 87.26
  • NWGL 2.81

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

About NWGL Nature Wood Group Limited

Nature Wood Group Ltd is a vertically-integrated forestry company that focuses on FSC business operations. It produces various products, including logs, decking, flooring, sawn timber, recycled charcoal, synthesized charcoal, machine-made charcoal, and essential oils. The Group owns natural forest concessions and cutting rights for exploiting timbers on parcels of land in Peru. The Group is organized into two operating divisions; Direct Purchase and Original Design Manufacturer (ODM) Services, and Manufacturing segments. The Direct Purchase and ODM Segment that derives the majority of revenue engages in the business of sourcing live wood and owning designed designs on wood products for sales to end customers. Geographically, the company generates a majority of its revenue from China.

Share on Social Networks: